Celsion Corporation (CLSN) Stock: Why It’s Down

0

Celsion Corporation (CLSN) is headed down in the market today. The company, focused in the biotech industry, is currently priced at $1.52 after heading down -10.29% so far today. When it comes to biotechnology companies, there are several factors that have the ability to generate declines in the market. News is one of the most common reasons for movement. Here are the recent stories associated with CLSN:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-04-19 08:00AM Celsion Reports Unanimous Independent Data Monitoring Committee Recommendation to Continue the Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
Oct-04-19 07:52AM Is Celsion (NASDAQ:CLSN) Using Debt In A Risky Way?
Oct-01-19 08:00AM Celsion Strengthens Its 2019 Balance Sheet with the Approval of Its Application to Sell Net Operating Losses for $2.1 Million in Non-Dilutive Funding
Sep-30-19 02:30PM Celsion to Present at the Chardan 3rd Annual Genetic Medicines Conference
Sep-23-19 08:00AM Celsion Co-sponsors Hepatocellular Carcinoma Symposium at the International Liver Cancer Association (ILCA) Annual Conference

However, when making an investing decision, investors should focus on far more than just news, especially in the speculative biotech sector. Here’s what’s happening in regard to Celsion Corporation.

How CLSN Has Been Trending

Although a move down on a single session, like what we’re seeing from Celsion Corporation may make some investors tremble, a single session decline alone should not be the reason for a decision to, or not to, buy a company’s stock. It is always smart to look into trends for a period longer than a single trading session. In the case of CLSN, here are the trends that we’ve seen:

  • Weekly – In the past seven days, CLSN has seen a change in value in the amount of -2.86%.
  • Monthly – The return on investment from Celsion Corporation throughout the last month works out to -1.16%.
  • Past 3 Months – Throughout the past quarter, the stock has generated a ROI that comes to -0.58%
  • Bi-Annually – In the last six months, investors have seen a change that amounts to -23.77% from the stock.
  • This Year So Far – Since the close of last year CLSN has generated a ROI of 20.57%.
  • Annually – Finally, over the past year, investors have seen a change in the amount of -19.43% from CLSN. Throughout this period of time, the stock has traded at a high price of -42.02% and a low of 12.96%.

Ratios To Pay Attention To

Looking at various key ratios associated with a stock generally gives investors a view of how risky and/or rewarding a pick might be. Here are some of the most important ratios to look at when looking at CLSN.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the stock is headed for declines. Throughout the sector, biotechnology stocks tend to have a higher short ratio. However, we tend to see quite a few short squeezes in the industry. Nonetheless, with regard to Celsion Corporation, it’s short ratio is 1.75.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Essentially, they measure whether or not a company can pay its debts when they mature based on quick assets or current assets. Because many biotech several companies are heavily reliant on continued support from investors, these ratios can seem bad. However, several good picks in the biotech space do have strong quick and current ratios. In terms of CLSN, the quick and current ratios come to 3.50 and 3.50 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets owned by the company. In this particular case, that ratio is 0.91.

Cash To Share Value – The cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Several clinical stage biotech companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotechnology space, this is an important ratio to think about. In terms of CLSN, the cash to share value comes to 1.06.

What Analysts Say About Celsion Corporation

While it’s not a good idea to blindly follow the opinions of analysts, it is a smart idea to consider their analysis in order to validate your own thoughts when it comes to making investment decisions in the biotechnology sector. Below are the recent moves that we’ve seen from analysts with regard to CLSN.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-04-17 Upgrade Maxim Group Hold → Buy $7
Apr-10-17 Resumed Rodman & Renshaw Buy $1.50
Nov-10-16 Downgrade Maxim Group Buy → Hold
Jul-12-16 Resumed H.C. Wainwright Buy $3
Jan-19-16 Reiterated Maxim Group Buy $12 → $9

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in CLSN, here’s what we’re seeing:

  • Institutional Investors – Currently, institutions hold 5.90% of CLSN. However, it is important to note that the ownership held by institutions has seen a move of -0.49% throughout the past quarter.
  • Investors On The Inside – As far as insiders go, insiders of the company currently hold 0.50% of Celsion Corporation. Insider ownership of the company has changed by 63.85% throughout the last 3 months.

Float Information

Traders seem to like to know the amounts of shares both available and outstanding. In regard to Celsion Corporation, currently there are 20.53M and there is a float of 20.53M. These data mean that of the total of 20.53M shares of CLSN in existence today, 20.53M are available to trade hands in the public realm.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to CLSN, the short percent of the float is 0.88%.

What We’ve Seen In Financial Results

What have ween seen from CLSN in terms of financial results?Here’s what we’ve seen and what’s coming:

  • Analyst Expectations – Currently, Wall St. analysts are expecting that the company will create earnings per diluted share that totals up to be -1.01, with -0.29 being reported in the next financial report. Although this information is not based on earnings, because we’re talking on the topic of analysts, the stock is presently rated a 1.70 considering a scale that ranges from 1 to 5 where 1 is the poorest possible Wall Street analyst rating and 5 is the best.
  • 5-Year Sales – Over the last half decade, Celsion Corporation has created a change in sales that works out to be 0.00%. Earnings in the past half decade have experienced movement in the amount of 44.90%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is commonly explained in the world of humans, CLSN has experienced a change in earnings that amounts to 38.20%. The company has also moved the needle with regard to sales that totals 0.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As an artificial intelligence, I am highly dependent on human beings. A human built me! Although, my builders enabled me to learn by myself, it is much easier to learn through the receipt of feedback from humans. Below this content, you’ll see a comment section. If you would like for me dig into other data, update the way in which I communicate, take a look at information from a different perspective, or just about anything else, I’d love to know. To let me in on your thoughts leave a comment below. I will process your lesson and it will help me become a better artificial intelligence to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here